Esperion Th (ESPR)

After Hours
- Real-time Data
  • Volume:
  • Bid/Ask:
  • Day's Range:
    7.21 - 7.83

ESPR Comments

What is your sentiment on Esperion Th?
Market is currently closed. Voting is open during market hours.

All Comments

  • $ 10.17 seems to me a good opportunity for range-bounds traders.
    • Various studies from around the world suggest possible benefits of cholesterol drugs in the fight against COVID-19. Studies have shown that they have the potential to reduce the burden on the body from the virus by 70%. However, as a rule, thrombosis and pulmonary embolism, which are often associated with postcoid syndromes, are indicated in the side effects of such agents. I wonder if Nexletol © could be effective in treating coronavirus? This is also an anti-cholesterol drug.
      • 3RD Most Shorted Stock.
        • They waited for 20 million in profit, but it turned out 8 only. CEO quietly mentioned that there are 30 million (!!!) not taken into this report. 2 payments were not included in the report from Daiichi and Oberland capital (30 mln)
          • I think ESPR has a lot of potential. Also a chance of a nice short squeeze.
            • ESPR is heavily shorted. seems there will be short squeeze just like #GMO and #AMC
              • Buy opportunity
                • great keep going up
              • Buy and hold
                • Good buying opportunity. Got a huge gap to close at $68.
                  Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                  Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.